<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Acromegaly":2,
"Breast cancer":17,
"Colon cancer":1,
"Pituitary":2,
"Thyroid cancer":22,
"5-Aminopyrazole-4-carboxamide":1,
"Metabolic stability":1,
"RET kinase":1,
"Specific inhibitor":1,
"Analogue":1,
"Calcitriol":1,
"Cancer":8,
"Prevention":1,
"Receptor":2,
"Treatment":1,
"Vitamin D":1,
"GH":1,
"IGF1":1,
"Canine":1,
"Hypothalamic-pituitary-thyroid axis":1,
"Hypothyroidism":3,
"Nonthyroidal illness":1,
"Tyrosine kinase inhibitors":2,
"Carcinoma":4,
"Papillary thyroid cancer":10,
"Prognosis":13,
"Thyroid neoplasms":11,
"Tumor staging":1,
"Molecular diagnostics":2,
"Next-generation sequencing":5,
"SETTLE":1,
"Thyroid":17,
"efflux pumps":1,
"polymorphisms":2,
"renal cell carcinoma":1,
"sunitinib":1,
"thyroid dysfunction":1,
"PNS antibodies":1,
"paraneoplastic optic neuropathy":1,
"paraneoplastic syndrome (PNS)":1,
"children":2,
"iodine supply":1,
"thyroid diseases":1,
"thyromegaly":1,
"Artificial pneumothorax":1,
"Carina":1,
"Mediastinal goiter":1,
"Prone position":1,
"Two-lung ventilation":1,
"Lateral neck node":1,
"Medullary thyroid carcinoma":6,
"Neck dissection":2,
"Survival":3,
"Systematic review":1,
"HER2":1,
"HER3":1,
"Phosphorylated HER3":1,
"Trastuzumab":1,
"breast cancer diagnosis":1,
"computed diffusion weighted imaging (cDWI)":1,
"diffusion weighted imaging (DWI)":1,
"voxelwise cDWI (vcDWI":1,
"Minimal extrathyroidal extension":1,
"Papillary thyroid carcinoma":18,
"Postoperative nonstimulated thyroglobulin":1,
"Radioiodine":1,
"124I":1,
"PET imaging":1,
"galectin-3":1,
"orthotopic models":1,
"thyroid tumor":1,
"Benign thyroid disease":1,
"Meta-analysis":1,
"Prospective study":1,
"Distant metastasis":1,
"Local infiltration":1,
"Poorly differentiated component":1,
"Thyroid papillary carcinoma":1,
"BRAF mutation":3,
"Fluorescent in situ hybridization":1,
"Iodine avidity":1,
"Lymph node metastases":1,
"Prognostic factor":1,
"RET/PTC rearrangement":1,
"Reverse transcription polymerase chain reaction":1,
"diagnosis":3,
"miRNA":3,
"thyroid disease":2,
"clinical parameter":1,
"gut microbiota":1,
"metabolite":1,
"predictive model":1,
"thyroid carcinoma":10,
"BAP1":1,
"BAP1-tumor predisposition syndrome":1,
"bilateral uveal melanoma":1,
"immunohistochemistry":5,
"in silico analysis":1,
"branchial cleft cyst":3,
"congenital":2,
"fourth branchial cleft cyst":1,
"pre-sternal region":1,
"unique location":1,
"16S rRNA gene sequencing":1,
"Clinical index":1,
"Gut microbiome":1,
"Thyroid nodules":5,
"cancer susceptibility candidate 2 (CASC2)":1,
"long noncoding RNA (lncRNA)":3,
"migration":4,
"papillary thyroid carcinoma (PTC)":1,
"proliferation":6,
"SEER program":1,
"propensity score":2,
"radiotherapy":3,
"biomarker":2,
"hypoxia-inducible factor 1 alpha (HIF1A)-antisense RNA 2 (HIF1A-AS2)":1,
"HOX transcript antisense RNA (HOTAIR)":1,
"gastric cancer (GC)":1,
"promoter analysis":1,
"cytology":3,
"oncocytic":1,
"poorly differentiated carcinoma":1,
"ThinPrep":1,
"cytologic features":1,
"tall cell variant":1,
"thyroid cytology":2,
"Capsular invasion":1,
"Follicular-patterned thyroid carcinoma":1,
"Gross examination":1,
"Vascular invasion":1,
"eosinophilia":1,
"molecular":1,
"mucoepidermoid":1,
"sclerosing":1,
"ultrasound":5,
"chyle leak":1,
"chylous fistula":1,
"postoperative complications":2,
"wound vac therapy":1,
"FNA":1,
"follow-up":1,
"large nodules":1,
"surgery":5,
"C cell hyperplasia":1,
"MEN2":1,
"Follicular thyroid carcinoma":2,
"IRAK1":1,
"TRAF6":1,
"miR146a":1,
"apoptosis":3,
"epithelial-mesenchymal transition":2,
"microRNA-539":1,
"secretory leukocyte protease inhibitor":1,
"transforming growth factor β1/Smads signaling pathway":1,
"Intrathyroidal ectopic thymus tissue":1,
"Atrophic glossitis":1,
"Gastric parietal cell antibody":1,
"Thyroglobulin antibody":1,
"Thyroid microsomal antibody":1,
"Hashimoto’s thyroiditis":2,
"Iodothyronine deiodinase":1,
"Thyroid gland":2,
"Thyroid hormone metabolism":1,
"TGF-β2":1,
"gastric cancer":1,
"miR-618":1,
"anaplastic":2,
"neoplasms":2,
"thyroid nodule":13,
"thyroidectomy":2,
"transoral robotic thyroidectomy":1,
"transoral thyroidectomy":1,
"fine-needle aspiration":4,
"spindle cell":1,
"thyroid follicular carcinoma":1,
"artificial neural network":1,
"bio-heat transfer":1,
"finite element analysis":1,
"thermography":1,
"thyroid gland tumors":1,
"Immune-checkpoint inhibitors":1,
"Nivolumab":2,
"Thyroiditis":3,
"Thyrotoxicosis":2,
"Bilaterality":2,
"Clonal origin":1,
"Early stage":1,
"Field cancerization":1,
"childhood cancer incidence":1,
"epidemiology":2,
"sex differences":1,
"Differentiated thyroid cancer":2,
"Lenvatinib":1,
"Multikinase inhibitor therapy":1,
"Radioactive iodine refractory":1,
"Sorafenib":1,
"core needle biopsy":2,
"fine needle aspiration":4,
"neck":1,
"ultrasonography":5,
"ultrasound guided needle biopsy":1,
"Lateral neck":1,
"Lymph node metastasis":4,
"Nomogram":1,
"Multimodal ultrasound Imaging":1,
"Real-time elastography":1,
"Superb microvascular imaging":1,
"Afirma Gene Expression Classifier":1,
"Molecular testing":5,
"ThyroSeq":1,
"Thyroid cytopathology":2,
"CD36":1,
"Dexmedetomidine":1,
"Resveratrol":2,
"Sirt1":1,
"Metastasis":4,
"Radioiodine-refractory PTC":1,
"anaplastic thyroid carcinoma":2,
"immune system":1,
"lymphocytes":1,
"monocytes":1,
"Fine needle aspiration (FNA)":1,
"NIFTP":2,
"Review":2,
"TBRSTC":1,
"Childhood":1,
"paediatric":1,
"radioactive iodine":2,
"Ageing population":1,
"Cancer incidence":1,
"Projections":1,
"Shanghai":1,
"Anterior pituitary":1,
"Hypopituitarism":1,
"Nonfunctioning pituitary adenoma":1,
"Pituitary surgery":1,
"Tumor size":1,
"Radioguided occult lesion localization":1,
"A meta-analysis":1,
"Excessive iodine intake":1,
"Urinary iodine":1,
"Lewis lung carcinoma":1,
"Tetrac":1,
"integrin αvβ3":1,
"thyroid hormone":1,
"thyroxine":1,
"tumor growth":1,
"EMT":3,
"Ruyiping":1,
"cell cycle":2,
"Calcitonin screening":1,
"MTC":1,
"Outcome":2,
"BRAF V600E":1,
"Extrathyroidal extension":1,
"RET/PTC1":1,
"Drug resistance":1,
"Euthyrox":1,
"MAP4K3":1,
"PTC":2,
"miR-206":1,
"sodium/iodide symporter":1,
"AKT/MAPK":1,
"Cervical cancer":1,
"Radioresistance":1,
"TRIP4":1,
"Telomerase":2,
"Active surveillance":1,
"Incidental":2,
"Microcarcinoma":2,
"Non-incidental":1,
"CDK7":1,
"PPP1R15A":1,
"THZ1":1,
"super-enhancer":1,
"transcriptional addiction":1,
"cabozantinib resistance":1,
"microRNAs":1,
"nanocells":1,
"targeted intravenous delivery":1,
"tumor suppressors":1,
"machine learning":3,
"random forest":1,
"death risk":1,
"hazard":1,
"recurrence risk":2,
"Cure models":1,
"Cure proportion":1,
"Population based cancer registry":1,
"Statistical cure":1,
"Time-to-cure":1,
"Benign thyroid nodules":1,
"Minimally invasive techniques":1,
"Radiofrequency ablation":2,
"Thermal ablation therapy":1,
"Aryl hydrocarbon receptor":1,
"Endocrine disruptor":1,
"Hexachlorobenzene":1,
"Mammary gland":1,
"Follicular variant of PTC":1,
"Personalized medicine":2,
"FTIR":1,
"Follicular thyroid adenoma":2,
"PCA-LDA":1,
"Raman spectroscopy":1,
"Evaluation of neck nodes":1,
"Head and neck ultrasound":1,
"Office-based ultrasound":1,
"Thyroid ultrasound":1,
"FAPI":1,
"PET/CT":1,
"colorectal cancer":2,
"lung cancer":2,
"growth":1,
"high-mobility group box 1 (HMGB1)":1,
"triptolide":1,
"adverse outcome":1,
"pregnancy":2,
"adrenal tumour":1,
"circadian rhythm":1,
"clock genes":1,
"ovarian tumour":1,
"parathyroid adenomas":1,
"pituitary adenomas":1,
"testis tumour":1,
"papillary carcinoma":3,
"RNA sequencing":1,
"immunogenomics":1,
"tumor immunology":1,
"age at diagnosis":1,
"genetic risk score":1,
"AKI stage":1,
"acute kidney injury":1,
"all-cause mortality":1,
"cancer treatment":1,
"nanoparticle albumin-bound paclitaxel":1,
"neoadjuvant chemotherapy":2,
"pathological complete response":1,
"GEF/GAP":1,
"MKP":1,
"RAS/ERK":1,
"scaffold":1,
"I/Cr ratio":1,
"Iodine nutrition":1,
"Urine iodine concentration":1,
"PET (Positron emission tomography)":1,
"PSMA (Prostate-specific membrane antigen)":1,
"Thyroid incidentaloma":1,
"CAFs":1,
"TCA cycle":1,
"anaplerosis":1,
"energy metabolism":1,
"heterogeneity":1,
"pyruvate carboxylase":1,
"reverse Warburg effect":1,
"tumor microenvironment":1,
"TRAIL":1,
"siRNA":1,
"tumor":3,
"BRAFV600E mutation":2,
"TERT promoter mutation":1,
"mechanism":1,
"CEA":1,
"Chromogranin A":1,
"Ki67":1,
"Prox1":1,
"Arsenic trioxide":1,
"Epithelial to mesenchymal transition":1,
"Hepatocellular carcinoma":2,
"Maternally expressed gene 3":1,
"Pyruvate kinase muscle isoform 2":1,
"Functional and oncological outcome":1,
"Retropharyngeal node":1,
"Cell proliferation and apoptosis":1,
"PI3K/Akt and GSK-3β/β-catenin cascades":1,
"Pseudolaric acid B":1,
"STAT3 and ERK pathways":1,
"Head and neck tumor":1,
"Lymph-node metastasis":1,
"Metastasis of unknown primary":1,
"neoplasm of the ureter":1,
"renal pelvic carcinoma":1,
"FOXD3-AS1":1,
"invasion":3,
"lncRNA":1,
"clinical validation":1,
"indeterminate cytology":1,
"Chinese Han population":1,
"IL1R1":1,
"IL1R2":1,
"association study":1,
"21-Gene oncotype Dx":1,
"Adjuvant decision-making":1,
"Independent predictors":1,
"Peptide P11":1,
"Signaling pathway":1,
"Prognostic marker":1,
"TRIP6":1,
"Therapeutic target":1,
"miR-7":1,
"CXCR1":1,
"EGFR":1,
"BRAF":1,
"E-cadherin":2,
"P53":1,
"Regional nodal recurrence":1,
"Malignant glomus tumor":1,
"chemotherapy":1,
"microscopy":1,
"CD56":1,
"Neuroendocrine":1,
"TTF-1":1,
"chromogranin":1,
"endometrial carcinoma":1,
"synaptophysin":1,
"Atypia of undetermined significance":1,
"Follicular neoplasm":1,
"Risk of malignancy":1,
"Sub-category":1,
"RP11-547D24 1":1,
"lncRNAs":1,
"Genetic screening":1,
"Multiple endocrine neoplasia":1,
"RET":1,
"AXIN2":1,
"bioinformatics analysis":1,
"polymorphism":2,
"Clinicopathological variables":1,
"ESCC":1,
"TRIP13":1,
"BRAF V600E mutation":2,
"Cancer tissues":1,
"LabSat":1,
"Microfluidic technology":1,
"RAI therapy":1,
"clinical response":1,
"Anaplastic thyroid cancer":2,
"BI-847325":1,
"Cyclin D1":1,
"MALAT1":1,
"Mcl1":1,
"miR-363-3p":1,
"Thyroid hormones":2,
"Thyroid stimulating hormone":1,
"Recurrence":2,
"Thyroid cancer, papillary":2,
"Thyrotropin":1,
"Biopsy, large-core needle":1,
"Pathology":2,
"Chinese herbal medicine":1,
"Xiaoaiping":1,
"alopecia,":1,
"chemotherapy-induced side effects":1,
"quality of life":1,
"HSDL2":1,
"NFATc2":1,
"PPP3CA":1,
"protein kinase B":1,
"PD-1 inhibitor":1,
"PDL-1 inhibitor":1,
"Pembrolizumab":1,
"Small cell carcinoma of ovary":1,
"poorly differentiated thyroid cancer":1,
"salidroside":1,
"Degenerating nodules":1,
"Imaging":1,
"Interstitial pneumonia":1,
"Mediastinal mass":1,
"Thorax":1,
"CDX2":1,
"ISL1":1,
"Neuroendocrine tumor":1,
"PAX8":1,
"SATB2":1,
"TTF1":1,
"immunotherapy":3,
"liquid biopsy":1,
"molecular pathology":1,
"next-generation sequencing (NGS)":1,
"thyroid fine-needle aspiration":1,
"hyalinizing trabecular tumor":1,
"immunocytochemistry":1,
"thyroid malignancy":2,
"central node dissection":1,
"multiple endocrine neoplasia type 2":2,
"prophylactic thyroidectomy":1,
"Nodules":1,
"Thyroid Imaging Reporting and Data System":2,
"Immune escape":1,
"Interleukin-17A":1,
"MHC class I molecule":1,
"PD-1/PD-L1":1,
"microRNA-423-3p":1,
"Papillary carcinoma of thyroid":1,
"Sistrunk’s procedure":1,
"Thyroglossal cyst":1,
"Total thyroidectomy":1,
"Disease-free survival":1,
"Nomograms":1,
"Overall survival":1,
"Stromal tumor-infiltrating lymphocytes":1,
"Triple negative breast cancer":1,
"laryngeal squamous cell carcinoma":1,
"lncRNA HOTAIR":1,
"lncRNA PTCSC3":2,
"AGEs":1,
"aminoguanidine":1,
"glyoxalase 1":1,
"methylglyoxal":1,
"Endometrial cancer":1,
"Endometrioid carcinoma":1,
"Medroxyprogesterone acetate therapy":1,
"Mesonephric-like adenocarcinoma":1,
"Müllerian duct":1,
"Chemokines":1,
"IGF-IEc":1,
"insulin-like growth factor-I (IGF-I)":1,
"MPPED2":1,
"MPPED2-AS1":1,
"long non-coding RNA":1,
"methylation":1,
"tumor suppressor":1,
"AKT":1,
"IGFBP7":1,
"Carcinome thyroïdien":1,
"Gen-Expressions-Classifier":1,
"Next-Generation-Sequencing":1,
"Schilddrüsenkarzinom":1,
"Thy":1,
"classificateur d’expression génique":1,
"gene expression classifier":1,
"molekulare Testung":1,
"séquençage de nouvelle génération":1,
"tests moléculaires":1,
"Environmental health":1,
"Health impact assessment":1,
"Randomized trial":1,
"Risk communication":1,
"Statistical indicators":1,
"Time needed to harm":1,
"Hashimoto's disease":1,
"clinicopathological characteristics":1,
"miRNA-146b-5p":1,
"Anti-PD-1 antibody":1,
"Dysfunction":1,
"Non-small cell lung cancer":1,
"organic nanoparticle":1,
"orthotopic liver cancer":1,
"photothermal therapy":1,
"second near-infrared":1,
"semiconducting polymer":1,
"Nondiagnostic cytology":1,
"malignancy":2,
"EGFR-sensitizing mutations":1,
"Stage IV lung adenocarcinoma":1,
"TTF-1 expression":1,
"Periodontal ligament stem cells":1,
"Periodontitis":1,
"Toll-like receptor 4":1,
"Follicular variant papillary thyroid cancer":1,
"Overtreatment":1,
"Biopsy":1,
"Cytodiagnosis":2,
"Fine-Needle":1,
"BRD4":1,
"TERT promoter":1,
"combined therapies":1,
"epigenetic drugs":1,
"telomeres":1,
"Dosimetry":1,
"Iodine refractory differentiated thyroid cancer":1,
"MEK inhibitor":1,
"Phase II":1,
"Radioiodoine therapy":1,
"Selumetinib":1,
"Local feature":1,
"Multi-direction":1,
"Non-quantitative":1,
"Rotation invariant":1,
"SVM classifier":1,
"Texture descriptor":1,
"three-dimensional power Doppler ultrasound":1,
"vascular indices":1,
"VOCAL":1,
"Statin":1,
"vascular endothelial growth factor":1,
"dyslipidemia":1,
"adiponectin":1,
"adipose tissue":1,
"endocrine cancer":2,
"obesity":1,
"liquid-based preparation":1,
"immunoPET":1,
"medullary thyroid carcinoma (MTC)":1,
"pretargeted imaging":1,
"radioimmunoconjugate":1,
"theranostic (therapeutic and diagnostic)":1,
"OCA2":1,
"Pathologic complete response":1,
"Rs4778137":1,
"Single nucleotide polymorphisms":1,
"CINCA Syndrome":1,
"NLRP3 MUTATION":1,
"cytopathology":1,
"diagnostic medicine":1,
"organ system pathology":1,
"pathology competencies":1,
"thyroid tumor staging":1,
"Activating anaplastic lymphoma kinase":1,
"Advanced non-small cell lung cancer":1,
"Adverse drug reaction":1,
"Anlotinib":1,
"Anti-angiogenesis":1,
"Epidermal growth factor receptor":2,
"National Medical Products Administration":1,
"cerebral hemorrhage":1,
"cumulative incidence":1,
"hazard ratio":1,
"infarction":1,
"stroke":1,
"Differentiated thyroid carcinoma":1,
"osteoporosis":1,
"thyroid-stimulating hormone suppression treatment":1,
"Risk factor":1,
"Epstein-Barr virus":1,
"Head and neck cancer":1,
"Human papillomavirus":1,
"Nasopharyngeal carcinoma":1,
"Toll-like receptor":1,
"PTEN":1,
"TERT":1,
"VEGF":1,
"tall cell":1,
"HTLV-1":1,
"clinicopathological factors":1,
"genetic abnormalities":1,
"genetic markers":1,
"oncogenic mutations":1,
"follicular thyroid cancer":1,
"genetics":1,
"whole-genome studies":1,
"locoregional failure":1,
"non-anaplastic":1,
"cancer intervention":1,
"Health disparities":1,
"Hispanic":1,
"Overdiagnosis":1,
"Puerto Rico":1,
"Ablation":1,
"Artificial intelligence":1,
"Database":1,
"Hyperthyroidism":1,
"Wearable electronic devices":1,
"Killer cells, natural":1,
"Programmed cell death 1":1,
"Biopsy, fine-needle":2,
"Tumor burden":1,
"BRAF, mutation":1,
"Genes, tumor suppressor":1,
"Neurofibromatosis 2":1,
"Proline rich 11 (PRR11)":1,
"S phase arrest":1,
"oncogene":1,
"tongue squamous cell carcinoma (TSCC)":1,
"Calcitonin":1,
"Diagnostics":1,
"Prophylactic lymph node dissection":1,
"Bulbar symptoms":1,
"Myasthenia gravis":1,
"F-actin":1,
"breast cancer cells":1,
"cytoskeleton":1,
"focal adhesion":1,
"live-cell imaging":1,
"microgravity":1,
"tubulin":1,
"vinculin":1,
"Carcinoma, medullary":1,
"Drug resistance neoplasms":1,
"Targeted therapy":1,
"Heart diseases":1,
"Perioperative care":1,
"adrenal":1,
"circulating miRNA":1,
"endocrine tumors":1,
"BRCA1 mutation":1,
"RET mutation":1,
"cancer genetics":1,
"medullary thyroid cancer":1,
"Beta catenin":1,
"Neoplastic stem cells":1,
"Sodium-iodine symporter":1,
"lymph node":1,
"thyroglobulin":1,
"DICER1":1,
"Sertoli–Leydig":1,
"genetic mutation":1,
"microrna":1,
"multinodular goiter":1,
"sex cord–stromal tumour":1,
"PI3K/AKT pathway":1,
"ROS":1,
"Vitamin C":1,
"AKR1C2":1,
"Expression":1,
"mutation":1,
"thyroid digenesis":1,
"autopsy":1,
"goiter":1,
"metastatic disease":1,
"dermatomyositis":1,
"inflammatory myopathy":1,
"polymyositis":1,
"thyroid gland papillary cancer":1,
"VASN":1,
"YAP/TAZ":1,
"epithelial-mesenchymal transition (EMT)":1,
"CASTLE":1,
"Chemoradiotherapy":1,
"Debulking surgery":1,
"cystic metastasis":1,
"neck neoplasms":1,
"Transoral endoscopic thyroidectomy":1,
"learning curve":1,
"patient and surgeon candidacy":1,
"vestibular approach":1,
"Case report":1,
"Cervix":1,
"Lung adenocarcinoma":1,
"Ovary":1,
"Cribriform-morular":1,
"familial adenomatous polyposis":1,
"Atypical cytology":1,
"Molecular tests":1,
"Noninvasive follicular thyroid neoplasms with papillary-like nuclear features":1,
"PMRT":1,
"local recurrence":1,
"risk factors":1,
"KLF11":1,
"NR4A3":1,
"combination therapy":1,
"hyperthermia":1,
"Adenocarcinoma, follicular":1,
"DJ-1":1,
"phosphatase":1,
"tensin homolog":1,
"MALT":1,
"lymphoma":1,
"non-hodgkin":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2019年6月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
